「不升级治疗」标识:一项多机构探索性定性研究
该定性研究在美国七家医院对30名医生进行半结构化访谈并审查相关机构记录,探讨医生如何理解和使用「不升级治疗」(NoET)标识及其机制。所有医院均报告使用NoET标识,其含义为不给予新的或更高强度的干预(「升级」),但不撤除正在进行的干预。三家医院提供了正式机制(如DNR/Do Not Escalate编码状态医嘱),其余医院使用口头交班等非正式方法。研究识别出NoET标识的五项功能,并发现各医院参与者均报告因NoET含义模糊而带来实施挑战。作者认为可通过实施正式机制提高一致性并明确每位患者「升级」的含义。
要点
- 所有七家受访医院均使用NoET标识,含义为不新增或加强干预(「升级」),但不撤除正在进行的干预。
- 仅三家医院有正式机制(如DNR/Do Not Escalate编码状态医嘱),其余医院依靠口头交班等非正式方法。
- NoET标识有五项功能:界定中间治疗限制点、帮助医生处理院前心脏骤停前的临床恶化、帮助代理决策者过渡到舒适照护、防止侵入性措施造成伤害、节约重症监护资源。
- 各医院参与者均报告NoET含义模糊导致实施挑战。
- 作者认为实施正式机制可鼓励提供者间一致性并明确每位患者「升级」的含义。
适用人群与场景
- 美国七家医院重症监护室(ICU)的危重症患者。
- 参与访谈的30名医生。
研究设计与关键结果
- 研究类型:多机构探索性定性研究,在美国七家医院对30名医生进行半结构化访谈,并审查相关机构记录(如医院政策、电子健康记录医嘱菜单截图)。
- 所有医院参与者均报告使用NoET标识,理解为提供者应不给予新的或更高强度干预(「升级」),但不撤除正在进行的干预。
- 三家医院提供将患者指定为NoET的具体机制(如DNR/Do Not Escalate编码状态医嘱);其余医院使用多种非正式方法(如口头交班)。
- 识别出NoET标识的五项功能:(1)界定中间治疗限制点;(2)帮助医生处理院前心脏骤停前的临床恶化;(3)帮助代理决策者过渡到舒适照护;(4)防止侵入性措施造成患者伤害;(5)节约重症监护资源。
- 各医院参与者均报告与NoET标识含义模糊相关的实施挑战。
证据类型、等级与局限
- 证据类型:探索性定性研究(七家美国医院,30名医生半结构化访谈及机构记录审查)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,尽管存在持续争论,NoET标识在多样化样本医院中被使用并被感知具有多重功能,提示其可能满足危重症患者照护中的重要需求,尤其是在生命终末期。
- 作者认为,可通过实施正式机制来改善NoET标识的使用,该机制鼓励提供者间的一致性并明确每位患者「升级」的含义。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: No Escalation of Treatment (NoET) designations are used in ICUs internationally to limit treatment for critically ill patients. However, they are the subject of debate in the literature and have not been qualitatively studied.
RESEARCH QUESTION: How do physicians understand and perceive NoET designations, especially regarding their usefulness and associated challenges? What mechanisms do hospitals provide to facilitate the use of NoET designations?
STUDY DESIGN AND METHODS: Qualitative study at seven US hospitals, employing semistructured interviews with 30 physicians and review of relevant institutional records (eg, hospital policies, screenshots of ordering menus in the electronic health record).
RESULTS: At all hospitals, participants reported the use of NoET designations, which were understood to mean that providers should withhold new or higher-intensity interventions ("escalations") but not withdraw ongoing interventions. Three hospitals provided a specific mechanism for designating a patient as NoET (eg, a DNR/Do Not Escalate code status order); at the remaining hospitals, a variety of informal methods (eg, verbal hand-offs) were used. We identified five functions of NoET designations: (1) Defining an intermediate point of treatment limitation, (2) helping physicians navigate prearrest clinical decompensations, (3) helping surrogate decision-makers transition toward comfort care, (4) preventing patient harm from invasive measures, and (5) conserving critical care resources. Across hospitals, participants reported implementation challenges related to the ambiguity in meaning of NoET designations.
INTERPRETATION: Despite ongoing debate, NoET designations are used in a varied sample of hospitals and are perceived as having multiple functions, suggesting they may fulfill an important need in the care of critically ill patients, especially at the end of life. The use of NoET designations can be improved through the implementation of a formal mechanism that encourages consistency across providers and clarifies the meaning of "escalation" for each patient.
参考来源
- Batten JN, Blythe JA, Wieten SE, et al. "No Escalation of Treatment" Designations: A Multi-institutional Exploratory Qualitative Study. Chest. 2022. PMID: 36007596. doi:10.1016/j.chest.2022.08.2211
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。